Sociedad Americana de Hirudoterapia

A four-year community hospital experience regarding procedures for the replantation and revascularization of fingers

Retrospective study published in Jt Dis Relat Surg (2021)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Research reportEnsayos clínicosGurbuz K et al. · Joint diseases and related surgery, 2021

Abstract

OBJECTIVES: This study aims to evaluate the clinical results and experiences in a community hospital regarding procedures for the replantation and revascularization of fingers. PATIENTS AND METHODS: Between June 2015 and December 2019, a total of 58 patients (51 males, 7 females; mean age: 33.4±6.3 years; range, 23 to 46 years) who were followed after total and/or subtotal amputation and replantation were retrospectively analyzed. The patients were evaluated at nine months in terms of cold intolerance, static two-point discrimination, and functional results using the range of motion (ROM) and Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire. RESULTS: The majority of the patients presented with work-related injuries (70%), most commonly by the mechanism of guillotine (64%), and to the dominant hand (76%) and the third finger (36%) most frequently. The overall success rate of digit salvage was 72.9% (n=51). Of 19 digits with unsuccessful surgical outcomes, seven were from total and 12 were from subtotal amputations. In the long-term, cold intolerance was observed in 14 patients (24.1%) according to the cold intolerance severity scale. The mean static two-point discrimination value was 6.0±0.7 mm and the mean QuickDASH score was 22.3±5.0. The mean ROM measured at nine months after surgery in the metacarpophalangeal and interphalangeal joints of the third and fourth digits was significantly lower than that in the others (p<0.05). CONCLUSION: The predictors of survival of a replanted digit indicated in this study can be used as a guide and decision-making aid for any attempts for replantation.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAdultAmputation, TraumaticCold TemperatureFemaleFinger InjuriesFinger JointFingersHospitals, CommunityHumansMaleMetacarpophalangeal JointMiddle Aged

Resumen

Community-hospital retrospective study of 58 patients with 72.9% digit-salvage success rate after finger replantation/revascularization.

Por qué esto importa para la hirudoterapia

Este estudio retrospectivo analizó 58 pacientes que fueron sometidos a reimplante o revascularización digital en un hospital comunitario durante cuatro años, reportando una tasa global de rescate del dígito del 72.9% y proporcionando datos sobre intolerancia al frío, discriminación de dos puntos y desenlaces funcionales. El estudio no menciona la terapia con sanguijuelas, hirudoterapia ni el manejo de la congestión venosa. No existe una relevancia defendible relacionada con sanguijuelas para el dominio de ASH en este artículo, que se enfoca completamente en la técnica quirúrgica y los predictores de desenlaces para el reimplante digital sin abordar ninguna terapia biológica adyuvante.

Citación

A four-year community hospital experience regarding procedures for the replantation and revascularization of fingers.

Gurbuz K et al. · Joint diseases and related surgery, 2021

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.